Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Use of the femoral vein ('groin injecting') by a sample of needle exchange clients in Bristol, UK | BioMed Central Harm Reduction Journal Research Open Access Use of the femoral vein groin injecting by a sample of needle exchange clients in Bristol UK John MaliphanC1 and Jenny Scott t2 Address 1Bristol Drugs Project 11 Brunswick Square Bristol BS2 8PE UK and 2Dept Pharmacy Pharmacology University of Bath Bath BA2 7AY UK Email John Maliphant - hst@ Jenny Scott - Corresponding author fEqual contributors Published 15 April 2005 Received 04 February 2005 Accepted 15 April 2005 Harm Reduction Journal 2005 2 6 doi 1477-7517-2-6 This article is available from http content 2 1 6 2005 Maliphant and Scott licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Use of the femoral vein for intravenous access by injecting drug users IDUs commonly called groin injecting is a practice that is often observed but on which little is written in the literature. The purpose of this study was to describe selfreported data from a sample of groin injectors on the natural history and rationale regarding their groin injecting to inform future research and the development of appropriate harm reduction strategies. Methods A convenience sample of groin injectors willing to participate in a semi-structured interview were recruited through the Bristol Drugs Project Harm Reduction Service. The interviews were conducted over the period of one week. Data on transition to groin injecting rationale for use and incidence of problems were collected. Results Forty seven IDUs currently injecting in their femoral vein groin were interviewed 66 n 31 male and 34 n 16 female. Their mean age was 31 yrs range 17 to 50 yrs SD . The mean length of time since first injecting episode was
